Funding Rounds
Alyssum Therapeutics October 2024 Series A Funding Round
Alyssum TherapeuticsAlyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells.
Summary
Stage: Series A
Raised Amount: $26.00M
Raised Date: 2024-10-23